Evotec and IMP will apply disease models to identify targets that Boehringer will chose from and further validate. Evotec, Boehringer Ingelheim, and the Research Institute of Molecular Pathology in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback